These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16410650)

  • 41. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the Low-Molecular-Weight Human Plasma Peptidome.
    Greening DW; Simpson RJ
    Methods Mol Biol; 2017; 1619():63-79. PubMed ID: 28674878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptidomics coming of age: a review of contributions from a bioinformatics angle.
    Menschaert G; Vandekerckhove TT; Baggerman G; Schoofs L; Luyten W; Van Criekinge W
    J Proteome Res; 2010 May; 9(5):2051-61. PubMed ID: 20377245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inconvenient truth: cancer biomarker development by using proteomics.
    Kondo T
    Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptidomics as a tool for characterizing bioactive milk peptides.
    Giacometti J; Buretić-Tomljanović A
    Food Chem; 2017 Sep; 230():91-98. PubMed ID: 28407976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.
    Cunningham R; Ma D; Li L
    Front Biol (Beijing); 2012 Aug; 7(4):313-335. PubMed ID: 24504115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of different statistical approaches for urinary peptide biomarker detection in the context of coronary artery disease.
    Stanley E; Delatola EI; Nkuipou-Kenfack E; Spooner W; Kolch W; Schanstra JP; Mischak H; Koeck T
    BMC Bioinformatics; 2016 Dec; 17(1):496. PubMed ID: 27923348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of Peptide tumor markers in a tumor graft model in immunodeficient mice.
    Tammen H; Schorn K; Selle H; Hess R; Neitz S; Reiter R; Schulz-Knappe P
    Comb Chem High Throughput Screen; 2005 Dec; 8(8):783-8. PubMed ID: 16464165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.
    Ménoret A; Crocker SJ; Rodriguez A; Rathinam VA; Clark RB; Vella AT
    Proteomics Clin Appl; 2016 Jan; 10(1):8-24. PubMed ID: 26201056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis.
    Ruiz-Romero C; Blanco FJ
    Osteoarthritis Cartilage; 2010 Apr; 18(4):500-9. PubMed ID: 20060947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biomarker discovery: proteome fractionation and separation in biological samples.
    Matt P; Fu Z; Fu Q; Van Eyk JE
    Physiol Genomics; 2008 Mar; 33(1):12-7. PubMed ID: 18162500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcending the biomarker mindset: deciphering disease mechanisms at the single cell level.
    Danna EA; Nolan GP
    Curr Opin Chem Biol; 2006 Feb; 10(1):20-7. PubMed ID: 16406766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A translational view of cells' secretome analysis - from untargeted proteomics to potential circulating biomarkers.
    Anjo SI; Manadas B
    Biochimie; 2018 Dec; 155():37-49. PubMed ID: 29782891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarker discovery in mass spectrometry-based urinary proteomics.
    Thomas S; Hao L; Ricke WA; Li L
    Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent developments and applications of capillary and microchip electrophoresis in proteomic and peptidomic analyses.
    Štěpánová S; Kašička V
    J Sep Sci; 2016 Jan; 39(1):198-211. PubMed ID: 26497009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteomic-based biomarker discovery for development of next generation diagnostics.
    Khalilpour A; Kilic T; Khalilpour S; Álvarez MM; Yazdi IK
    Appl Microbiol Biotechnol; 2017 Jan; 101(2):475-491. PubMed ID: 28013407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.